文献速递肝病

非酒精性脂肪性肝炎患者MRI-PDFF变化与组织学应答:系统综述与Meta分析

Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-08-31

该系统综述与Meta分析检索截至2020年5月的早期临床试验,纳入7项研究346例非酒精性脂肪性肝炎(NASH)成人患者,比较MRI-PDFF应答者(肝脏脂肪相对下降≥30%)与无应答者的组织学应答和NASH缓解情况。结果显示MRI-PDFF应答者组织学应答率51% vs 14%(OR 6.98,95%CI 2.38-20.43,P<.001),NASH缓解率41% vs 7%(OR 5.45,95%CI 1.53-19.46,P=.009),均显著高于无应答者。

要点

  • MRI-PDFF应答(肝脏脂肪相对下降≥30%)者组织学应答率51% vs 无应答者14%,OR 6.98(95%CI 2.38-20.43,P<.001)。
  • MRI-PDFF应答者NASH缓解率41% vs 无应答者7%,OR 5.45(95%CI 1.53-19.46,P=.009)。
  • 结果支持在早期NASH临床试验中使用MRI-PDFF无创监测治疗应答。

核心结论

  • MRI-PDFF相对下降≥30%与更高的组织学应答和NASH缓解几率相关。
  • 结果支持在早期NASH临床试验中使用MRI-PDFF无创监测治疗应答,并为基于组织学评估的样本量估算提供数据。

研究设计与样本

  • 系统综述与Meta分析,检索Cochrane Library、Embase、Medline和试验注册库至2020年5月。
  • 纳入7项早期临床试验,共346例成人NASH受试者(中位年龄51岁;59%女性;46%患糖尿病)。
  • 受试者分为MRI-PDFF应答者(肝脏脂肪相对下降≥30%)与无应答者(相对下降<30%)进行比较。

主要发现

  • MRI-PDFF应答者组织学应答(NAFLD活动度评分改善2分且小叶内炎症或气球样变至少改善1分)率51% vs 无应答者14%(P<.001;OR 6.98,95%CI 2.38-20.43,P<.001)。
  • MRI-PDFF应答者NASH缓解率41% vs 无应答者7%(P<.001;OR 5.45,95%CI 1.53-19.46,P=.009)。

关键数值与推荐

  • MRI-PDFF应答定义为肝脏脂肪相对下降≥30%,无应答定义为相对下降<30%。
  • 主要结局为组织学应答:NAFLD活动度评分改善2分且小叶内炎症或气球样变至少改善1分。
  • 次要结局为NASH缓解。

临床怎么用

  • 原文结论支持在早期NASH临床试验中使用MRI-PDFF无创监测治疗应答,并为基于组织学评估的样本量估算提供数据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Magnetic resonance imaging proton density fat fraction (MRI-PDFF) offers promise as a non-invasive biomarker of treatment response in early-phase nonalcoholic steatohepatitis (NASH) trials. We performed a systematic review to quantify the association between a ≥ 30% reduction in MRI-PDFF and histologic response in NASH. METHODS: We searched the Cochrane Library, Embase, Medline and trial registries through May 2020 for early-phase clinical trials that incorporated MRI-PDFF and examined histologic response following intervention in adults with NASH. Subjects were classified as MRI-PDFF responders (relative decline in liver fat ≥30%) or non-responders (relative decline in liver fat <30%). MRI-PDFF responders versus non-responders were compared. Primary outcome was histologic response defined as a 2-point improvement in NAFLD Activity Score with at least 1-point improvement in lobular inflammation or ballooning. Secondary outcome was NASH resolution. Proportions and random effects odds ratios (OR) with corresponding 95% confidence intervals (CI) were calculated. RESULTS: Seven studies met inclusion criteria, comprising 346 subjects (median age 51 years; 59% female; 46% with diabetes). MRI-PDFF responders were significantly more likely to have a histologic response (51% vs 14%, P < .001; OR 6.98, 95% CI 2.38-20.43, P < .001) and NASH resolution (41% vs 7%, P < .001; OR 5.45, 95% CI 1.53-19.46, P = .009) compared to non-responders. CONCLUSIONS: This meta-analysis demonstrates that a ≥30% relative decline in MRI-PDFF is associated with higher odds of histologic response and NASH resolution. These results support the use of MRI-PDFF in non-invasive monitoring of treatment response in early-phase NASH clinical trials and provide helpful data for sample-size estimation for histology-based assessment.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Stine JG, Munaganuru N, Barnard A, et al. Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2020. PMID: 32882428. doi:10.1016/j.cgh.2020.08.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。